Author

Wenlan Zang

Pfizer (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Fridrik J. KarlssoniD· 1 shared Jie QuaniD· 1 shared Praveen Krishna VeerasubramanianiD· 1 shared Thomas A. WynniD· 1 shared Vijaya Amancha· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Fridrik J. KarlssonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combination antagonism of TNF superfamily signaling for T cell immunosuppression

Praveen Krishna Veerasubramanian, Wenlan Zang, Vijaya Amancha, Thomas A. Wynn, Jie Quan, Fridrik J. Karlsson

This study evaluates TNF/TNFR combinations for immunosuppression, finding that four drug combinations significantly reduce T cell cytokine production and gene activation in allogeneic responses.

Frontiers in Immunology · Jul 23, 2026Peer-reviewedImmunology